摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(2-氧代-1,2-二氢-4-喹啉基)乙酸 | 21298-80-6

中文名称
(2-氧代-1,2-二氢-4-喹啉基)乙酸
中文别名
(2-氧代-1,2-二氢-喹啉-4-基)-乙酸
英文名称
2-(2-oxo-1,2-dihydroquinoline-4-yl)acetic acid
英文别名
2-oxo-1,2-dihydroquinoline-4-acetic acid;2-oxo-1,2-dihydroquinolin-4-acetic acid;2-oxo-1H-4-quinolinylacetic acid;(2-oxo-1,2-dihydro-quinolin-4-yl)-acetic acid;2-oxo-1,2-dihydro-4-quinolineacetic acid;4-Carboxymethyl-carbostyril;2-(2-oxo-1H-quinolin-4-yl)acetic acid
(2-氧代-1,2-二氢-4-喹啉基)乙酸化学式
CAS
21298-80-6
化学式
C11H9NO3
mdl
——
分子量
203.197
InChiKey
UXVHMJOEWPQFFT-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.3
  • 重原子数:
    15
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.09
  • 拓扑面积:
    66.4
  • 氢给体数:
    2
  • 氢受体数:
    3

安全信息

  • 海关编码:
    2933499090

SDS

SDS:2be2f556c3a249cb892fec81b467358f
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    • 1
    • 2

反应信息

  • 作为反应物:
    描述:
    (2-氧代-1,2-二氢-4-喹啉基)乙酸 在 lithium aluminium tetrahydride 、 氯化亚砜 作用下, 以 四氢呋喃 为溶剂, 反应 2.0h, 生成 4-(2-hydroxyethyl)quinolin-2-(1H)-one
    参考文献:
    名称:
    Studies on 2(1H)-quinolinone derivatives as gastric antiulcer active agents. 2-(4-Chlorobenzoylamino)-3-(2(1H)-quinolinon-4-yl)propionic acid and related compounds.
    摘要:
    合成了一系列N-酰基氨基酸类似物的2 (1H)-喹啉酮,并测试了它们对醋酸诱导的大鼠胃溃疡的抗溃疡活性。这些化合物是通过酰化2 (1H)-喹啉酮的氨基酸衍生物合成的,这些衍生物是通过ω-溴烷基2 (1H)-喹啉酮和乙酰胺基丙二酸酯在乙醇钠存在下反应,然后与稀盐酸水解得到的。其中,2-(4-氯苯甲酰氨基)-3-[2 (1H)-喹啉酮-4-基]丙酸(VIIIf)显示出最强的活性。讨论了结构活性关系。
    DOI:
    10.1248/cpb.33.3775
  • 作为产物:
    描述:
    参考文献:
    名称:
    Synthesis and SAR of 3- and 4-substituted quinolin-2-ones: discovery of mixed 5-HT1B/5-HT2A receptor antagonists
    摘要:
    Quinolin-2-ones bearing a heteroaryl-piperazine linked by a two carbon chain at the 3- or 4-position were synthesised and evaluated as mixed 5-HT1B/5-HT2A receptor antagonists. Potent mixed antagonists were obtained with thieno[3,2-c]pyridine derivatives. In this series, compound 2.1 (SL 65.0472) proved to be functional antagonist at both the 5-HT2A receptor (rat in vivo 5-HT-induced hypertension model) and the 5-HT1B receptor (dog in vitro saphenous vein assay). (C) 2001 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0968-0896(01)00118-3
点击查看最新优质反应信息

文献信息

  • Quinolinone derivatives and their preparation in therapy
    申请人:Synthelabo
    公开号:US04983607A1
    公开(公告)日:1991-01-08
    A quinolinone derivative which is a compound of formula (I): ##STR1## in which: R.sub.1 and R.sub.2 are each, independently of one another, a hydrogen or halogen atom or a (C.sub.1-4)alkyl radical; R.sub.3 is a hydrogen atom or a (C.sub.1-4)alkyl radical; R.sub.4 is an unsubstituted or substituted naphthyl, tetrahydronaphthyl, benzyl, phenyl, pyridyl, isoquinolyl or benzoyl radical; and X and Y are each a hydrogen atom or together form a bond; or a pharmaceutically acceptable acid addition salt thereof and, when X and Y are each a hydrogen atom, the diastereoisomers and enantiomers thereof.
    一种喹啉酮衍生物,其化学式为(I):##STR1##其中:R.sub.1和R.sub.2分别独立地是氢原子或卤素原子或(C.sub.1-4)烷基基团;R.sub.3是氢原子或(C.sub.1-4)烷基基团;R.sub.4是未取代或取代的萘基、四氢萘基、苄基、苯基、吡啶基、异喹啉基或苯甲酰基基团;X和Y分别是氢原子或一起形成键;或其药学上可接受的酸盐,当X和Y分别是氢原子时,其对映异构体和对映体。
  • Studies on 2(1H)-quinolinone derivatives as gastric antiulcer active agents. 2-(4-Chlorobenzoylamino)-3-(2(1H)-quinolinon-4-yl)propionic acid and related compounds.
    作者:MINORU UCHIDA、FUJIO TABUSA、MAKOTO KOMATSU、SEIJI MORITA、TOSHIMI KANBE、KAZUYUKI NAKAGAWA
    DOI:10.1248/cpb.33.3775
    日期:——
    A series of N-acyl amino acid analogues of 2 (1H)-quinolinone was synthesized and tested for antiulcer activity against acetic acid-induced gastric ulcer in rats. These compounds were synthesized by the acylation of amino acid derivatives of 2 (1H)-quinolinone, which were obtained from the reaction of ω-bromoalkyl 2 (1H)-quinolinones and acetamidomalonate in the presence of sodium ethoxide, followed by hydrolysis with diluted hydrochloric acid. Among them, 2-(4-chlorobenzoylamino)-3-[2 (1H)-quinolinon-4-yl] propionic acid (VIIIf) was found to have the most potent activity. The structure-activity relationships are discussed.
    合成了一系列N-酰基氨基酸类似物的2 (1H)-喹啉酮,并测试了它们对醋酸诱导的大鼠胃溃疡的抗溃疡活性。这些化合物是通过酰化2 (1H)-喹啉酮的氨基酸衍生物合成的,这些衍生物是通过ω-溴烷基2 (1H)-喹啉酮和乙酰胺基丙二酸酯在乙醇钠存在下反应,然后与稀盐酸水解得到的。其中,2-(4-氯苯甲酰氨基)-3-[2 (1H)-喹啉酮-4-基]丙酸(VIIIf)显示出最强的活性。讨论了结构活性关系。
  • [EN] COMPOUNDS FOR THE TREATMENT OF HIV<br/>[FR] COMPOSÉS POUR TRAITER LE VIH
    申请人:GILEAD SCIENCES INC
    公开号:WO2013006738A1
    公开(公告)日:2013-01-10
    The invention provides compounds of formula (I): or a salt thereof as described herein. The invention also provides pharmaceutical compositions comprising a compound of formula (I), processes for preparing compounds of formula (I), intermediates useful for preparing compounds of formula I and therapeutic methods for treating a Retroviridae viral infection including an infection caused by the HIV virus.
    本发明提供了如下式(I)的化合物或其盐,还提供了包含如下式(I)化合物的药物组合物,制备如下式(I)化合物的方法,用于制备如下式(I)化合物的中间体以及治疗Retroviridae病毒感染的治疗方法,包括由HIV病毒引起的感染。
  • COMPOUNDS FOR THE TREATMENT OF HIV
    申请人:Bondy Steven S.
    公开号:US20140142085A1
    公开(公告)日:2014-05-22
    The invention provides compounds of formula (I): or a salt thereof as described herein. The invention also provides pharmaceutical compositions comprising a compound of formula (I), processes for preparing compounds of formula (I), intermediates useful for preparing compounds of formula I and therapeutic methods for treating a Retroviridae viral infection including an infection caused by the HIV virus.
    本发明提供了以下式子(I)的化合物或其盐,如本文所述。本发明还提供了包括式子(I)化合物的制药组合物,制备式子(I)化合物的方法,用于制备式子I化合物的中间体以及治疗逆转录病毒感染的治疗方法,包括由HIV病毒引起的感染。
  • Compounds for the treatment of HIV
    申请人:Gilead Sciences, Inc.
    公开号:US10370358B2
    公开(公告)日:2019-08-06
    The invention provides compounds of formula (I): or a salt thereof as described herein. The invention also provides pharmaceutical compositions comprising a compound of formula (I), processes for preparing compounds of formula (I), intermediates useful for preparing compounds of formula I and therapeutic methods for treating a Retroviridae viral infection including an infection caused by the HIV virus.
    本发明提供如本文所述的式(I)化合物或其盐。本发明还提供了包含式(I)化合物的药物组合物、制备式(I)化合物的工艺、用于制备式(I)化合物的中间体以及治疗逆转录病毒科病毒感染(包括由 HIV 病毒引起的感染)的治疗方法。
查看更多